Mark A Munger (Mark Munger)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Venues

Pharmacotherapy

International journal of molecular sciences

Pharmacy practice

University of Utah

Oregon State University Press (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Utah

United States

Professor :: Pharmacotherapy and Internal Medicine

Education History

Oregon State University Press

United States

BSC

Publications

Julie L Barr, Michael Feehan, Casey R Tak, Leah A Owen, Robert C Finley, Parker A Cromwell, John H Lillvis, Patrice M Hicks, Elizabeth Au, Michael H Farkas, Asher Weiner, Andrew L Reynolds, Sandra F Sieminski, Richard M Sherva, Mark A Munger, Murray H Brilliant, Margaret M DeAngelis
Heritable Risk and Protective Genetic Components of Glaucoma Medication Non-Adherence. International journal of molecular sciences 24 (6) (2023)
Julie L Barr, Michael Feehan, Casey R Tak, Leah A Owen, Robert C Finley, Parker A Cromwell, John H Lillvis, Patrice M Hicks, Elizabeth Au, Michael H Farkas, Asher Weiner, Andrew L Reynolds, Sandra F Sieminski, Richard M Sherva, Mark A Munger, Murray H Brilliant, Margaret M DeAngelis
Heritable Risk and Protective Genetic Components of Glaucoma Medication Non-Adherence. International journal of molecular sciences 24 (6) (2023)
Isaac Nay, Doug Hutchinson, Matthew Rondina, Kibum Kim, Rachel Kroencke, Amanda Kirkham, Toby Trujillo, Neal D Tolley, Mark A Munger
Prospective, randomized, controlled, trial to assess ASA DOSing by body mass index in HEalthy volunteers (DOSE study). Pharmacotherapy 43 (3) (2023)
Donald P Alexander, Nancy A Nickman, Anindit Chhibber, Gregory Stoddard, Joseph E Biskupiak, Mark A Munger
Authors response to critique of "angiotensin-converting enzyme inhibitors reduce community-acquired pneumonia hospitalization and mortality". Pharmacotherapy 43 (3) (2023)
Isaac Nay, Doug Hutchinson, Matthew Rondina, Kibum Kim, Rachel Kroencke, Amanda Kirkham, Toby Trujillo, Neal D Tolley, Mark A Munger
Prospective, randomized, controlled, trial to Assess ASA DOSing by Body Mass Index in HEalthy Volunteers (DOSE Study). Pharmacotherapy (2023)
Isaac Nay, Doug Hutchinson, Matthew Rondina, Kibum Kim, Rachel Kroencke, Amanda Kirkham, Toby Trujillo, Neal D Tolley, Mark A Munger
Prospective, randomized, controlled, trial to assess ASA DOSing by body mass index in HEalthy volunteers (DOSE study). Pharmacotherapy (2023)
Isaac Nay, Doug Hutchinson, Matthew Rondina, Kibum Kim, Rachel Kroencke, Amanda Kirkham, Toby Trujillo, Neal D Tolley, Mark A Munger
Prospective, randomized, controlled, trial to assess ASA DOSing by body mass index in HEalthy volunteers (DOSE study). Pharmacotherapy 43 (3) (2023)
Julie L Barr, Michael Feehan, Casey R Tak, Leah A Owen, Robert C Finley, Parker A Cromwell, John H Lillvis, Patrice M Hicks, Elizabeth Au, Michael H Farkas, Asher Weiner, Andrew L Reynolds, Sandra F Sieminski, Richard M Sherva, Mark A Munger, Murray H Brilliant, Margaret M DeAngelis
Heritable Risk and Protective Genetic Components of Glaucoma Medication Non-Adherence. International journal of molecular sciences 24 (6) (2023)
Donald P Alexander, Nancy A Nickman, Anindit Chhibber, Gregory Stoddard, Joseph E Biskupiak, Mark A Munger
Authors response to critique of "angiotensin-converting enzyme inhibitors reduce community-acquired pneumonia hospitalization and mortality". Pharmacotherapy 43 (3) (2023)
Isaac Nay, Doug Hutchinson, Matthew Rondina, Kibum Kim, Rachel Kroencke, Amanda Kirkham, Toby Trujillo, Neal D Tolley, Mark A Munger
Prospective, randomized, controlled, trial to assess ASA DOSing by body mass index in HEalthy volunteers (DOSE study). Pharmacotherapy 43 (3) (2023)
Mark A Munger, Scott D Nelson, Chia-Chen Teng, Alfred K Cheung, Brian C Sauer
Reduced risk of NSAID-Induced adverse events with concomitant use of misoprostol (MICRO study). Pharmacotherapy 42 (7) (2022)
Donald P Alexander, Nancy A Nickman, Anindit Chhibber, Gregory J Stoddard, Joseph E Biskupiak, Mark A Munger
Angiotensin-converting enzyme inhibitors reduce community-acquired pneumonia hospitalization and mortality. Pharmacotherapy (2022)
Fady Allahwerdy, Steven Pan, Michael Feehan, Aubrey E Jones, Mark A Munger, Daniel M Witt
A descriptive study of antithrombotic medication patterns in adult patients with recent venous thromboembolism. Pharmacy practice 17 (3) (2019)

Mark A Munger.css-eqlu8i{font-size:small;padding-left:4px;} (Mark Munger)

Publication Activity (10 Years)

Top Topics

Top Venues

Mark A Munger (Mark Munger)